Health Care·Biotechnology·$351.5B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.13 | N/A | +0.44% |
management commentary, guidance changes, and full analysis available with Pro.
| +0.44% |
Tone: Cautiously Optimistic
Overall, management expressed confidence in their product pipeline and market position. However, they did not provide specific guidance for future quarters.
Management highlighted the continued strength in their core products.
They emphasized ongoing investments in research and development.
AbbVie's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 1.7% on the day, likely due to the lack of revenue data and absence of forward guidance, which may have left investors feeling uncertain about future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
CORNING INC
Jan 26, 2016